Skip to content

Drug interactions

Enalapril-hydrochlorothiazide + Glecaprevir / pibrentasvir

Severity: Minor

Enalapril-hydrochlorothiazide and Glecaprevir / pibrentasvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glecaprevir and pibrentasvir inhibit OATP1B1/1B3 and may increase exposure to enalapril, a substrate of hepatic uptake and prodrug conversion pathways. The clinical significance is likely small, but exaggerated blood pressure lowering is possible.

What this interaction means in plain words

Enalapril-hydrochlorothiazide and Glecaprevir / pibrentasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Inhibition of OATP1B1/1B3 transporters by glecaprevir/pibrentasvir, possibly raising enalapril concentrations.

What to do

No routine dose change is needed; monitor blood pressure and renal function when starting the antiviral course.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enalapril-hydrochlorothiazide and Glecaprevir / pibrentasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Enalapril-hydrochlorothiazide with Glecaprevir / pibrentasvir?

MediHelp rates the interaction as minor. Enalapril-hydrochlorothiazide and Glecaprevir / pibrentasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Glecaprevir and pibrentasvir inhibit OATP1B1/1B3 and may increase exposure to enalapril, a substrate of hepatic uptake and prodrug conversion pathways. The clinical significance is likely small, but exaggerated blood pressure lowering is possible.

How serious is the interaction between Enalapril-hydrochlorothiazide and Glecaprevir / pibrentasvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor blood pressure and renal function when starting the antiviral course.

What other medicines interact with Enalapril-hydrochlorothiazide?

MediHelp also lists interactions of Enalapril-hydrochlorothiazide with, for example, Aliskiren, Dofetilide, Protein a column. The full list is on the Enalapril-hydrochlorothiazide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in